Oral administration of different dietary supplements during injection with D-galactose and aluminum chloride reduced the elevation in plasma levels of acetylcholinesterase and butrylcholinesterase significantly compared with the rats’ group of Alzheimer’s disease. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.